Trino Therapeutics, a drug development firm spun-out of Trinity College, Dublin’s (TCB) School of Pharmacy, has raised over €9m ($12m) series A funding. The round was led by VC firm Fountain Healthcare Partners and charitable foundation the Wellcome Trust, a founding investor in Trino. Joining in participation are government agency Enterprise Ireland and investment vehicle…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
